Pharmacology, Toxicology and Pharmaceutical Science
Fluorouracil
100%
Folinic Acid
51%
Malignant Neoplasm
44%
Pharmacokinetics
35%
Colon Cancer
28%
Neoplasm
26%
Solid Malignant Neoplasm
23%
Dipyridamole
23%
Chemotherapy
21%
Cytarabine
19%
1 (4,5 Dihydroxy 3 Hydroxymethyl 2 Cyclopenten 1 Yl)cytosine
19%
Colorectal Cancer
18%
Gemcitabine
17%
Floxuridine
17%
Methotrexate
16%
Thymidylate Synthase
15%
9 Aminocamptothecin
15%
Clinical Trial
15%
Cytotoxicity
14%
Phase I Trials
13%
Alpha2a Interferon
12%
Irinotecan
12%
Colon Carcinoma
12%
Pharmacodynamics
12%
Dihydropyrimidine Dehydrogenase
11%
Oxaliplatin
11%
Gastrointestinal Carcinoma
11%
Pentostatin
11%
Fazarabine
11%
Lactone
10%
Anticarcinogen
10%
Disease
10%
Hairy Cell Leukemia
10%
Interferon
9%
Nucleoside
9%
Diarrhea
9%
High Performance Liquid Chromatography
9%
Thymidine
8%
Folinate Calcium
8%
Pancreas Adenocarcinoma
7%
Nelfinavir
7%
Metastatic Colorectal Cancer
7%
2 (2 Dimethylaminoethyl) 9 Methoxy 5 nitropyrazolo[3,4,5 Kl]acridine
7%
5 Ethynyluracil
7%
Maximum Tolerated Dose
7%
Thymidine Triphosphate
7%
Creatinine
6%
Neutropenia
6%
Murine Leukemia
6%
Metastasis
5%
Keyphrases
5-fluorouracil (5-FU)
36%
Leucovorin
29%
Fluorouracil
19%
Colon Cancer
19%
NCCN Guidelines
16%
Small Bowel Adenocarcinoma
15%
Metastatic Colorectal Cancer (mCRC)
15%
Metastatic Disease
13%
Colorectal Cancer
12%
Advanced Colorectal Cancer
12%
Phase I Study
11%
Arabinofuranosylcytosine
11%
9-aminocamptothecin
11%
Oncology
11%
Systemic Therapy
10%
Pharmacologic
9%
Adult Cancer Patients
9%
Thymidylate Synthase
9%
Survivorship
8%
Phase II Study
7%
Gemcitabine
7%
Colorectal Cancer Cells
7%
Tumor
7%
Weekly Schedule
7%
Clinical Practice Guidelines
7%
17-allylamino-17-demethoxygeldanamycin
7%
Granulocyte Colony-stimulating Factor (G-CSF)
6%
Lactones
6%
Cancer Panel
6%
Recurrent Disease
6%
Surgical Management
6%
Pathological Stage
6%
Treatment Selection
5%
FOLFOX
5%
Cytotoxicity
5%
Perioperative Care
5%
Chemical Modulation
5%
Interferon-α (IFN-α)
5%
Colloidal Dispersion
5%
Chemotherapy
5%
Thymidine Phosphorylase
5%
Medicine and Dentistry
Colon Cancer
27%
Metastatic Carcinoma
27%
Rectum Cancer
23%
Surgery
22%
Disease
15%
Metastatic Colorectal Cancer
13%
Oncology
12%
FOLFOX
12%
Anus Carcinoma
11%
Survivorship in Cancer Care
11%
Neoplasm
9%
Recurrent Disease
9%
Pancreas Cancer
9%
Hairy Cell Leukemia
9%
Adjuvant Therapy
7%
Pancreas Adenocarcinoma
7%
Oxaliplatin
7%
Folinic Acid
7%
Fluorouracil
7%
Pentostatin
7%
FOLFIRI
7%
Malignant Neoplasm
6%
Adjuvant Chemotherapy
6%
Capecitabine
6%
Gemcitabine
5%
Systemic Therapy
5%
Clinical Trial
5%
Bevacizumab
5%
Mitomycin
5%
Large-Cell Lymphoma
5%